# Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)

> **NCT00014989** · PHASE3 · COMPLETED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 2136 (actual)

## Conditions studied

- Cerebral Palsy
- Intraventricular Hemorrhage
- Periventricular Leukomalacia
- Pulmonary Edema
- Abruptio Placentae

## Interventions

- **DRUG:** magnesium sulfate

## Key facts

- **NCT ID:** NCT00014989
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** 2007-02
- **Final completion:** 2007-06
- **Target enrollment:** 2136 (ACTUAL)
- **Last updated:** 2019-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014989, "Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00014989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*